Literature DB >> 16103048

Restarting the cell cycle when the checkpoint comes to a halt.

Marcel A T M van Vugt1, Alexandra Bràs, René H Medema.   

Abstract

The DNA damage checkpoint coordinates a block in cell proliferation with the DNA repair process that follows when lesions are inflicted on the genome. However, we do not know exactly how cell division can recommence following a DNA damage-induced arrest. Recent work from our lab has identified Polo-like kinase-1 and Cdc25B as two essential components of the machinery that sets the cell division process back in motion when the checkpoint response is abrogated. Here, we discuss these novel insights and discuss their possible implications for the treatment of cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16103048     DOI: 10.1158/0008-5472.CAN-05-1054

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  Global phosphoproteome profiling reveals unanticipated networks responsive to cisplatin treatment of embryonic stem cells.

Authors:  Alex Pines; Christian D Kelstrup; Mischa G Vrouwe; Jordi C Puigvert; Dimitris Typas; Branislav Misovic; Anton de Groot; Louise von Stechow; Bob van de Water; Erik H J Danen; Harry Vrieling; Leon H F Mullenders; Jesper V Olsen
Journal:  Mol Cell Biol       Date:  2011-10-17       Impact factor: 4.272

2.  A genetic screen identifies BRCA2 and PALB2 as key regulators of G2 checkpoint maintenance.

Authors:  Tobias Menzel; Viola Nähse-Kumpf; Arne Nedergaard Kousholt; Ditte Kjærsgaard Klein; Christin Lund-Andersen; Michael Lees; Jens Vilstrup Johansen; Randi G Syljuåsen; Claus Storgaard Sørensen
Journal:  EMBO Rep       Date:  2011-07-01       Impact factor: 8.807

Review 3.  Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy.

Authors:  Klaus Strebhardt
Journal:  Nat Rev Drug Discov       Date:  2010-08       Impact factor: 84.694

4.  Chromatin regulators and their impact on DNA repair and G2 checkpoint recovery.

Authors:  Veronique A J Smits; Ignacio Alonso-de Vega; Daniël O Warmerdam
Journal:  Cell Cycle       Date:  2020-07-30       Impact factor: 4.534

5.  Effect of antisense RNA targeting Polo-like kinase 1 on cell growth in A549 lung cancer cells.

Authors:  Qiong Zhou; Yuan Su; Ming Bai
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-02

6.  Cdc25B dual-specificity phosphatase inhibitors identified in a high-throughput screen of the NIH compound library.

Authors:  Paul A Johnston; Caleb A Foster; Marni Brisson Tierno; Tong Ying Shun; Sunita N Shinde; William D Paquette; Kay M Brummond; Peter Wipf; John S Lazo
Journal:  Assay Drug Dev Technol       Date:  2009-06       Impact factor: 1.738

7.  Cyclic pifithrin-alpha sensitizes wild type p53 tumor cells to antimicrotubule agent-induced apoptosis.

Authors:  Valentina Zuco; Franco Zunino
Journal:  Neoplasia       Date:  2008-06       Impact factor: 5.715

8.  The Initiation of Meiotic Sex Chromosome Inactivation Sequesters DNA Damage Signaling from Autosomes in Mouse Spermatogenesis.

Authors:  Hironori Abe; Kris G Alavattam; Yueh-Chiang Hu; Qishen Pang; Paul R Andreassen; Rashmi S Hegde; Satoshi H Namekawa
Journal:  Curr Biol       Date:  2020-01-02       Impact factor: 10.834

9.  The Set1/COMPASS histone H3 methyltransferase helps regulate mitosis with the CDK1 and NIMA mitotic kinases in Aspergillus nidulans.

Authors:  Meera Govindaraghavan; Sarah Lea Anglin; Aysha H Osmani; Stephen A Osmani
Journal:  Genetics       Date:  2014-05-15       Impact factor: 4.562

Review 10.  Tumor heterogeneity: mechanisms and bases for a reliable application of molecular marker design.

Authors:  Salvador J Diaz-Cano
Journal:  Int J Mol Sci       Date:  2012-02-13       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.